文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2008 年欧洲痴呆症的经济影响-欧洲规范项目的成本估算。

The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.

机构信息

Alzheimeŕs Disease Research Center, NCS, Karolinska Institute, Stockholm, Sweden.

出版信息

Int J Geriatr Psychiatry. 2011 Aug;26(8):825-32. doi: 10.1002/gps.2610. Epub 2010 Oct 28.


DOI:10.1002/gps.2610
PMID:21744385
Abstract

OBJECTIVE: Care for demented people is very resource demanding, the prevalence is increasing and there is so far no cure. Cost of illness (CoI) studies are important by identifying the distribution of costs between different payers of care. The European Union (EU) funded the European Collaboration on Dementia (Eurocode) as part of the EU's 2005 work plan of the Community public health programme. Eurocode was administered by Alzheimer Europe. The aim was to describe the economic impact of dementia in Europe in 2008. METHODS: Eurocode's new estimates for dementia prevalence were included in a cost model based on published European CoI papers. For countries where no CoI figures were available, imputation was used. RESULTS: The total CoI of dementia in the EU27 in 2008 was estimated to be €160 billion (€22 000 per demented per year), of which 56% were costs of informal care. The corresponding costs for the whole Europe was €177 billion. In northern Europe, the direct costs are estimated to be considerabe, while the cost of informal care is the major cost component in southern Europe. The sensitivity analysis showed a range for total EU27 costs between €111 and 168 billion. CONCLUSIONS: The estimated CoI in this study is higher than in previous studies. There are also large differences in different European regions. Notwithstanding the methodological challenges, the societal costs of dementia in Europe are very high which in turn have substantial resource impacts on the social and health care systems in Europe.

摘要

目的:照顾痴呆患者需要大量资源,其患病率正在上升,目前尚无治愈方法。疾病成本(CoI)研究通过确定不同护理支付者之间的成本分配很重要。欧盟(EU)资助了欧洲痴呆症合作研究(Eurocode),作为欧盟 2005 年社区公共卫生计划的一部分。Eurocode 由阿尔茨海默病欧洲协会管理。目的是描述 2008 年欧洲痴呆症的经济影响。

方法:将 Eurocode 对痴呆症患病率的新估计纳入基于已发表的欧洲 CoI 论文的成本模型中。对于没有 CoI 数据的国家,使用了估算。

结果:2008 年欧盟 27 国痴呆症的总 CoI 估计为 1600 亿欧元(每位痴呆症患者每年 22000 欧元),其中 56%是非正式护理的成本。整个欧洲的相应成本为 1770 亿欧元。在北欧,直接成本估计相当大,而在南欧,非正式护理成本是主要的成本组成部分。敏感性分析显示,欧盟 27 国总费用的范围在 1110 亿至 1680 亿欧元之间。

结论:本研究中的估计 CoI 高于以前的研究。不同的欧洲地区也存在很大差异。尽管存在方法学挑战,但欧洲痴呆症的社会成本非常高,这反过来对欧洲的社会和卫生保健系统产生了重大的资源影响。

相似文献

[1]
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.

Int J Geriatr Psychiatry. 2010-10-28

[2]
The worldwide societal costs of dementia: Estimates for 2009.

Alzheimers Dement. 2010-3

[3]
Cost of depression in Europe.

J Ment Health Policy Econ. 2006-6

[4]
Estimating the cost of epilepsy in Europe: a review with economic modeling.

Epilepsia. 2007-12

[5]
The economic costs of dementia in Korea, 2002.

Int J Geriatr Psychiatry. 2006-8

[6]
Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.

Mult Scler. 2007-9

[7]
Cost of dementia in the pre-enlargement countries of the European Union.

J Alzheimers Dis. 2011

[8]
An estimate of the worldwide prevalence and direct costs of dementia in 2003.

Dement Geriatr Cogn Disord. 2006

[9]
Cost estimates of brain disorders in Belgium.

Acta Neurol Belg. 2006-12

[10]
An estimate of the total worldwide societal costs of dementia in 2005.

Alzheimers Dement. 2007-4

引用本文的文献

[1]
Economic evaluation of non-pharmacological interventions in Alzheimer's disease.

Dement Neuropsychol. 2025-6-2

[2]
Therapeutic Options in Alzheimer's Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity.

Life (Basel). 2024-11-26

[3]
Cognitive and physical impact of combined exercise and cognitive intervention in older adults with mild cognitive impairment: A systematic review and meta-analysis.

PLoS One. 2024

[4]
Comparison of regional vs. general anesthesia on the risk of dementia: a systematic review and meta-analysis.

Front Public Health. 2024

[5]
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study).

J Alzheimers Dis. 2023

[6]
Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.

Nutrients. 2023-3-24

[7]
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study.

Eur J Health Econ. 2023-12

[8]
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann-Pick disease type C.

Int J Clin Pharm. 2022-12

[9]
Costs of Persons with Dementia Living in Nursing Homes in The Netherlands.

J Alzheimers Dis. 2022

[10]
Combined Motor and Cognitive Rehabilitation: The Impact on Motor Performance in Patients with Mild Cognitive Impairment. Systematic Review and Meta-Analysis.

J Pers Med. 2022-2-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索